Lopez-Pousa S

References (12)

Title : Characteristics of patients with Alzheimer's disease who switch to rivastigmine transdermal patches in routine clinical practice - Lopez-Pousa_2013_Patient.Prefer.Adherence_7_47
Author(s) : Lopez-Pousa S , Arranz FJ
Ref : Patient Prefer Adherence , 7 :47 , 2013
PubMedID: 23341737

Title : [Cognitive decline in Alzheimer's disease. A follow three or more years of a sample of patients] - Conde-Sala_2013_Rev.Neurol_56_593
Author(s) : Conde-Sala JL , Garre-Olmo J , Vilalta-Franch J , Llinas-Regla J , Turro-Garriga O , Lozano-Gallego M , Hernandez-Ferrandiz M , Pericot-Nierga I , Lopez-Pousa S
Ref : Rev Neurol , 56 :593 , 2013
PubMedID: 23744245

Title : Use of antidementia drugs in frontotemporal lobar degeneration - Lopez-Pousa_2012_Am.J.Alzheimers.Dis.Other.Demen_27_260
Author(s) : Lopez-Pousa S , Calvo-Perxas L , Lejarreta S , Cullell M , Melendez R , Hernandez E , Bisbe J , Perkal H , Manzano A , Roig AM , Turro-Garriga O , Vilalta-Franch J , Garre-Olmo J
Ref : Am J Alzheimers Dis Other Demen , 27 :260 , 2012
PubMedID: 22605780

Title : Consumption of pharmaceuticals in primary non-Alzheimer's degenerative dementias : a cross-sectional study by the Registry of Dementias of Girona (ReDeGi) - Lopez-Pousa_2012_Drugs.Aging_29_733
Author(s) : Lopez-Pousa S , Turro-Garriga O , Calvo-Perxas L , Carmona O , Gich J , Alsina E , Marquez F , Vinas M , Turbau J , Vilalta-Franch J , Roig AM , Garre-Olmo J
Ref : Drugs & Aging , 29 :733 , 2012
PubMedID: 23018609

Title : [Metabolic syndrome in Alzheimer's disease: clinical and developmental influences] - Vilalta-Franch_2008_Rev.Neurol_46_13
Author(s) : Vilalta-Franch J , Lopez-Pousa S , Garre-Olmo J , Turon-Estrada A , Pericot-Nierga I
Ref : Rev Neurol , 46 :13 , 2008
PubMedID: 18214821

Title : [Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs] - Vilalta-Franch_2008_Rev.Neurol_46_129
Author(s) : Vilalta-Franch J , Lopez-Pousa S , Garre-Olmo J , Turon-Estrada A , Pericot-Nierga I
Ref : Rev Neurol , 46 :129 , 2008
PubMedID: 18297617

Title : [Mortality-associated factors in patients with Alzheimer's disease treated with galantamine.] - Lopez-Pousa_2006_Med.Clin.(Barc)_127_206
Author(s) : Lopez-Pousa S , Garre Olmo J , Vilalta Franch J , Turon Estrada A , Soler Cors O , Pericot Nierga I
Ref : Med Clin (Barc) , 127 :206 , 2006
PubMedID: 16938240

Title : Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine - Lopez-Pousa_2006_Age.Ageing_35_365
Author(s) : Lopez-Pousa S , Olmo JG , Franch JV , Estrada AT , Cors OS , Nierga IP , Gelada-Batlle E
Ref : Age Ageing , 35 :365 , 2006
PubMedID: 16788079

Title : Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period - Lopez-Pousa_2005_Dement.Geriatr.Cogn.Disord_19_189
Author(s) : Lopez-Pousa S , Turon-Estrada A , Garre-Olmo J , Pericot-Nierga I , Lozano-Gallego M , Vilalta-Franch M , Hernandez-Ferrandiz M , Morante-Munoz V , Isern-Vila A , Gelada-Batlle E , Majo-Llopart J
Ref : Dementia & Geriatric Cognitive Disorders , 19 :189 , 2005
PubMedID: 15677866

Title : [Treatment for non-cognitive symptoms in Alzheimer's disease] - Vilalta-Franch_1999_Rev.Neurol_29_819
Author(s) : Vilalta-Franch J , Lopez-Pousa S , Llinas-Regla J
Ref : Rev Neurol , 29 :819 , 1999
PubMedID: 10696656

Title : [Treatment of Alzheimer's disease: acetylcholinesterase inhibitors]. - Lopez-Pousa_1999_Neurologia_14_180
Author(s) : Lopez-Pousa S , Lombardia Fernandez C
Ref : Neurologia , 14 :180 , 1999
PubMedID: 10363493

Title : [Medical treatment of Alzheimer's disease]. - Lopez-Pousa_1998_Rev.Neurol_26_1054
Author(s) : Lopez-Pousa S , Serra-Mestres J
Ref : Rev Neurol , 26 :1054 , 1998
PubMedID: 9658492